Meetings/Workshops on Immunology and Allergic Diseases in the United Kingdom

Select a location
Superbugs & Superdrugs — SMi’s 22nd Annual Superbugs & Superdrugs Conference
30 Mar 2020 - 31 Mar 2020 • London, United Kingdom
SMi Group
As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless. This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.
Phone: [02078276000];     Email:
Resistance; superbugs; superdrugs; mrsa; infectious diseases; investment; smart materials, infection, drug discovery, antibacterial, antimicrobial, anti-infective, multidrug resistance, MDR, diagnostics, immunization, inhibitors, antibiotic, resistance, antibiotic resistance, vaccine, bacterial, infections, drive a-b, genome sequencing, multi-resistant gram-negative, BARDA, Microbiota, EBOLA, bacteria, biotech, biomedical, pem, disease, amr, ppp, health, containment, microbiology, hepatitis, hcv, clinical, lab, gram positive, gram negative, fungi, fungal, population, contamination, viral, virus, amr, zika, fda, pathogen
Event listing ID:
Related subject(s):
5th Annual Advances in Immuno-Oncology Congress
21 May 2020 - 22 May 2020 • London, United Kingdom
Oxford Global Conferences
Immuno-Oncology, Cancer Immunology, Cancer Vaccines, Immunotherapy, Oncology Cell Therapy, Antibody Development, T-Cell Engineering, Immune Biology, Combination Therapy, CAR-T Cell Therapy, Checkpoint Inhibitors, Bispecific, Assay Development, Cancer Genetics/Genomics, Personalised Medicine, Biomarker, Translational Immunology, Preclinical Development, Clinical Oncology, Clinical Trial Management, Clinical Development
Event listing ID:
Related subject(s): offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Last updated: 15 November 2019